European Health AI Companies Preparing for Stock Market Debuts

Europe's healthcare technology and artificial intelligence sectors are entering a new phase. After the pandemic boom ended and investment dried up, these companies have become more disciplined and professionally managed. Now, the strongest ones are ready to take the next big step: going public on the stock market.

When a company goes public (also called an IPO or Initial Public Offering), it means the company sells shares to the general public for the first time. This allows investors to own a piece of the company, and it gives the company access to large amounts of money to grow. For healthcare companies using AI — like those developing tools to diagnose diseases or manage patient data — this is a major milestone.

According to recent analysis, Europe has about 10 promising candidates from the health AI and medical device sectors that could debut on stock markets between 2026 and 2028. These companies have weathered a difficult period when venture capital (money from investors betting on startups) became scarce. Those that survived did so by focusing on real products, actual customers, and sustainable business models — not just impressive technology.

For everyday people, this matters because it signals that European health innovation is serious and competitive. Public companies face stricter oversight and transparency requirements, which can benefit patients and users. It also means these technologies — whether they're AI tools for doctors or new medical devices — are becoming real products that will likely reach more hospitals and clinics across Europe.